BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 6162946)

  • 1. A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release.
    Norton SK; Dellinger A; Zhou Z; Lenk R; Macfarland D; Vonakis B; Conrad D; Kepley CL
    Clin Transl Sci; 2010 Aug; 3(4):158-69. PubMed ID: 20718816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Apr; 197(1):153-62. PubMed ID: 57234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings].
    Foreman JC; Hallett MB; Mongar JL
    Br J Pharmacol; 1977 Mar; 59(3):473P-474P. PubMed ID: 402969
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiallergic compounds.
    Davies RJ; Moodley I
    Pharmacol Ther; 1982; 17(3):279-97. PubMed ID: 6187031
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent advances in antiallergic pharmacotherapy].
    Müller U
    Med Klin; 1977 Nov; 72(45):1901-8. PubMed ID: 412042
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro.
    Free CA; Hall LE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):437-40. PubMed ID: 6162946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
    Cox JS
    Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.